The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia

• Sanne Noort,
• Priscilla Wander,
• Todd A. Alonzo,
• Jenny Smith,
• Rhonda E. Ries,
• Robert B. Gerbing,
• M. Emmy M. Dolman,
• Franco Locatelli,
• Dirk Reinhardt,
• Andre Baruchel,
• Jan Stary,
• Jan J. Molenaar,
• Ronald W. Stam,
• Marry M. van den Heuvel-Eibrink,
• C. Michel Zwaan,
• Soheil Meshinchi

Affiliations

Sanne Noort

Pediatric Oncology/Hematology, Erasmus MC-Sophia Children Hospital Rotterdam, The Netherlands;

Priscilla Wander

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;

Todd A. Alonzo

Children's Oncology Group, Monrovia, California, USA;

Jenny Smith

Fred Hutchinson Cancer Research Center, Seattle, Washington, USA;

Rhonda E. Ries

Fred Hutchinson Cancer Research Center, Seattle, Washington, USA;

Robert B. Gerbing

Children's Oncology Group, Monrovia, California, USA;

M. Emmy M. Dolman

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;

Franco Locatelli

IRCCS Ospedale Bambino Gesú, Sapienza, University of Rome, Rome, Italy;

Dirk Reinhardt

AML-BFM Study Group, Pediatric Hematology and Oncology, Essen, Germany;

Andre Baruchel

University Hospital Robert Debré and Paris Diderot University, Paris, France;

Jan Stary

CPH, University Hospital Motol and Charles University, Prague, Czech Republic;

Jan J. Molenaar

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;

Ronald W. Stam

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;

Marry M. van den Heuvel-Eibrink

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;

C. Michel Zwaan

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;

Soheil Meshinchi

Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, USA